Home | EACH/PIC Coalition

Calling All Patients and Caregivers: Share Your Perspective On Prescription Drugs

We support reducing prescription drug costs and want to ensure health reforms truly benefit patients. For that to happen, patients and caregivers need to share their experiences.

Existing Prescription Drug Affordability Boards (PDABs)

Does your state have an active Prescription Drug Administration Board (PDAB)? Many states have active PDABs. Hover over your state to learn more. (Updated as of April 1, 2025)

Legislative Outlook for 2025

This map demonstrates 2025 legislation that has been introduced (or expected) for the purpose of creating PDABs or capping drug prices. (Updated as of April 1, 2025)

Uniting to Support Patient-First Drug Policies

EACH unites patient organizations and allied groups to collectively advocate for patient-first drug affordability policies that protect access to medications.

Empowering Patients & Caregivers to Participate

The PIC aims to empower patients and caregivers to shape healthcare policy through peer-led education, perspective sharing, and activities to ensure patient-reported needs are incorporated into drug affordability solutions.

Advocating for Patient-Driven Policy Solutions

The EACH/PIC Coalition agrees there is a need to address high prescription drug costs for patients. We promote treatment affordability policies that consider patient needs first. We are concerned that the growing movement to conduct cost-reviews and implement payment limits on individual drugs are not sufficiently focused on patient needs and could lead to unintended consequences for patients.

May Compromise Patient Access

Cost reviews create a new incentive structure for payers that could compromise patient access to the selected medications due to increased utilization management or reshuffling of formularies.

Possible Barriers to Care

Failing to resolve the underlying factors that lead to higher costs for patients can result in short-term relief and uneven benefits – aiding some but potentially leaving others with higher costs and drug accessibility challenges.

Patient Experiences Should Drive Change

Focusing singularly on drug prices ignores the complicated nature of our healthcare marketplace and fails to resolve the underlying factors that lead to higher costs for patients.